{"id":29965,"date":"2024-12-18T13:47:49","date_gmt":"2024-12-18T12:47:49","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=29965"},"modified":"2024-12-18T13:47:51","modified_gmt":"2024-12-18T12:47:51","slug":"antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/","title":{"rendered":"Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030"},"content":{"rendered":"\n<p>L\u2019European Center for Disease Prevention and Controle (ECDC) a publi\u00e9 son\u00a0<a href=\"https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/antimicrobial-consumption-ESAC-Net-annual-epidemiological-report-2023_0.pdf\">rapport annuel<\/a>\u00a0dans le cadre de la journ\u00e9e europ\u00e9enne d\u2019information sur les antibiotiques. Ce dernier souligne l\u2019\u00e9loignement de l\u2019UE de ses objectifs pour 2030 en termes de lutte contre la RAM.\u00a0En effet entre 2019 et 2023, l\u2019UE a vu sa consommation d\u2019ATB augmenter de 1%, alors que l\u2019objectif fix\u00e9 pr\u00e9voit une r\u00e9duction de 20% d\u2019ici 2030 par rapport \u00e0 2019. Par ailleurs, une augmentation de la consommation d\u2019ATB critiques list\u00e9s par l\u2019OMS a aussi \u00e9t\u00e9 relev\u00e9e, avec une \u00e9l\u00e9vation de 0,4% entre 2019 et 2023.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019European Center for Disease Prevention and Controle (ECDC) a publi\u00e9 son\u00a0rapport annuel\u00a0dans le cadre de la journ\u00e9e europ\u00e9enne d\u2019information sur les antibiotiques. Ce dernier souligne l\u2019\u00e9loignement de l\u2019UE de ses objectifs pour 2030 en termes de lutte contre la RAM.\u00a0En effet entre 2019 et 2023, l\u2019UE a vu sa consommation d\u2019ATB augmenter de 1%, alors [&hellip;]<\/p>\n","protected":false},"author":280,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,37],"tags":[6697,6607,6733,6698,6621],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030 - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030 - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-18T12:47:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-18T12:47:51+00:00\" \/>\n<meta name=\"author\" content=\"Kevin Gr\u00e9goire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kevin Gr\u00e9goire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/\"},\"author\":{\"name\":\"Kevin Gr\u00e9goire\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\"},\"headline\":\"Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030\",\"datePublished\":\"2024-12-18T12:47:49+00:00\",\"dateModified\":\"2024-12-18T12:47:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/\"},\"wordCount\":114,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"keywords\":[\"AMR\",\"Antibior\u00e9sistance\",\"Antibiotic Resistance\",\"Antimicrobial Resistance\",\"OneHealth\"],\"articleSection\":[\"Actualit\u00e9s\",\"Bilans, rapports et recommandations\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/\",\"name\":\"Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030 - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"datePublished\":\"2024-12-18T12:47:49+00:00\",\"dateModified\":\"2024-12-18T12:47:51+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\",\"name\":\"Kevin Gr\u00e9goire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030 - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/","og_locale":"fr_FR","og_type":"article","og_title":"Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030 - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2024-12-18T12:47:49+00:00","article_modified_time":"2024-12-18T12:47:51+00:00","author":"Kevin Gr\u00e9goire","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Kevin Gr\u00e9goire","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/"},"author":{"name":"Kevin Gr\u00e9goire","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700"},"headline":"Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030","datePublished":"2024-12-18T12:47:49+00:00","dateModified":"2024-12-18T12:47:51+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/"},"wordCount":114,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"keywords":["AMR","Antibior\u00e9sistance","Antibiotic Resistance","Antimicrobial Resistance","OneHealth"],"articleSection":["Actualit\u00e9s","Bilans, rapports et recommandations"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/","name":"Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030 - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"datePublished":"2024-12-18T12:47:49+00:00","dateModified":"2024-12-18T12:47:51+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioresistance-lunion-europeenne-progresse-difficilement-vers-ses-objectifs-2030\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Antibior\u00e9sistance : l\u2019Union europ\u00e9enne progresse difficilement vers ses objectifs 2030"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700","name":"Kevin Gr\u00e9goire"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-18 13:37:14","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/29965"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/280"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=29965"}],"version-history":[{"count":2,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/29965\/revisions"}],"predecessor-version":[{"id":29967,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/29965\/revisions\/29967"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=29965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=29965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=29965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}